ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : University/Organization : Blumenthal Cancer Center at Carolinas Medical Center

Include trials that are no longer recruiting patients.

4 studies were found.
1.RecruitingHigh-Dose Intravenous Interleukin-2 in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer) That Has Not Responded to Previous Low-Dose Intravenous or Subcutaneous Interleukin-2
Conditions: recurrent renal cell cancer; Stage IV Renal Cell Cancer
2.No longer recruitingInterferon alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
Conditions: Stage IV Renal Cell Cancer; recurrent renal cell cancer
3.No longer recruitingInterleukin-2 in Treating Patients With Metastatic Melanoma
Conditions: Stage IV Melanoma; Recurrent Melanoma
4.No longer recruitingInterleukin-2 in Treating Patients With Metastatic or Recurrent Kidney Cancer
Conditions: Stage IV Renal Cell Cancer; recurrent renal cell cancer

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act